At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
In Brief
A Phase 2 clinical trial evaluating Frovatriptan and Placebo for Medication Overuse Headache and Analgesic Overuse Headache. Completed, enrolled 55 participants across 1 site.
Detailed Summary
This study will analyze the effectiveness of a medication called Frovatriptan, in the context of medication overuse headache (MOH). MOH is a headache that develops when pain-killers are taken frequently. The treatment is to stop the overuse of these pain-killers, but that can sometimes worsen the headache first before it gets better. We are testing Frovatriptan against placebo to see if it can help patients with this transition and avoid the worsening of the headache that can occur. We will also see if Frovatriptan can help in other ways, such as maintain patients free of medication overuse.
Study Details
Timeline
Interventions
2.5 mg po bid for 10 days
1 tab po bid for 10 days